← Eichor
Condition: Antiretroviral Therapy Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Antiretroviral Therapy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The MARVIN Chatbots to Provide Information for Different Health Conditions
NA · 2 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT05789901Structured Peer-delivered ART and Reentry Community Strategy
NA · 1 location(s) · Johns Hopkins University · NCT06027671The DART DELIVER-02 Study
Phase 1 · 3 location(s) · University of North Carolina, Chapel Hill · NCT07217379Post-Injectable Cabotegravir Antiretroviral Salvage Strategy Options Trial
Phase 4 · 3 location(s) · University of Witwatersrand, South Africa · NCT06485154Strategies to AchieVe Viral Suppression for Youth With HIV
NA · 1 location(s) · Johns Hopkins University · NCT06886971Hybrid Type-1 Effectiveness-Implementation Trial of Motivation Matters!
NA · 1 location(s) · University of Washington · NCT06745050Study of Autophagy and the Effects of GALIG Gene Products in HIV-1 Infected Patients Who Are Under Antiretroviral Therap
Phase N/A · 1 location(s) · Centre Hospitalier Régional d'Orléans · NCT04160455A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
Phase 2 · 123 location(s) · ViiV Healthcare · NCT07202546Gathering Records to Evaluate Antiretroviral Treatment-South Africa
Phase N/A · 1 location(s) · Boston University · NCT04149782STARLITE for Unresectable High-Grade Gliomas
Phase 1 · 1 location(s) · University of Miami · NCT06428045Integrated Mental Health Care for Pregnant Women With HIV in Kenya: The Tunawiri Study
NA · 1 location(s) · University of Colorado, Denver · NCT06117163Gathering Records to Evaluate Antiretroviral Treatment-Zambia (GREAT )
Phase N/A · 1 location(s) · Boston University · NCT04158882Outcomes of the PLHIV With Suboptimal Viral Suppression to Injectable Long-acting Antiretrovirals
Phase 3 · 4 location(s) · Chang Gung Memorial Hospital · NCT06507059Switch to Dolutegravir Plus Lamivudine Dual-Therapy in Transgender Women Living With HIV on Virologically Suppressive An
Phase 4 · 1 location(s) · UBATEC · NCT06967753Variation in Drug Interactions in People With HIV (PLWH) Aged 60 Years and Older.
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06717581Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretrovir
Phase 1 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06819176Post Analytic Treatment Interruption Study
Phase N/A · 1 location(s) · SEARCH Research Foundation · NCT02761200Low Dose Nivolumab in Adults Living With HIV on Antiretroviral Therapy
Phase 1/Phase 2 · 2 location(s) · University of Melbourne · NCT05187429Observational Study on Patients With HIV/AIDS(OSPWH)
Phase N/A · 1 location(s) · Guangzhou 8th People's Hospital · NCT04667026Exploration of the Variability of Exposure to Antiretroviral Treatment in Hair With a View to Validating Its Value as a
Phase N/A · 1 location(s) · University Hospital, Toulouse · NCT07062614Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adult
Phase 3 · 3 location(s) · Gilead Sciences · NCT07682961Impacts of HIV Treatment Regimens on Archived Drug Resistance
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT07643948Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05419024Optimization of Antiretroviral Therapy in Patients With AIDS-Related Lymphoma
NA · 1 location(s) · Shanghai Public Health Clinical Center · NCT07727642Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART Control
Phase 2 · 17 location(s) · ANRS, Emerging Infectious Diseases · NCT05300035Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment
Phase 3 · 6 location(s) · Johns Hopkins University · NCT06497465Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Pa
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00039689Exploratory Study of LP-98 for Injection in ART-Naive HIV-Infected Individuals
Phase 1/Phase 2 · 1 location(s) · Shanxi Kangbao Biological Product Co., Ltd. · NCT07433387Efficacy of Doravirine + Dolutegravir Dual Therapy in the Context of Antiretroviral Therapy Switch
Phase 3 · 3 location(s) · Chelsea and Westminster NHS Foundation Trust · NCT04892654Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy
Phase 2 · 1 location(s) · Abdelrahman Mahmoud · NCT07336797
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.